About
Melissa Lokugamage is a participant in AbbVie's Strategic Leadership Program and is involved in building new companies at 82VS. She holds a Ph.D. in Biomedical Engineering from Georgia Tech, with research focusing on non-hepatic delivery of lipid nanoparticles, nucleic acids, nanomedicine, and non-viral delivery modalities.
Experience
- AbbVieStrategic Leadership Programcurrent2026 — presentChicago, IL
- 82VSVenture Principal2025 — 2026Boston, MA
- 82VSSenior Venture Associate2023 — 2025Boston, Massachusetts, United States
- 82VSVenture Associate2021 — 2023Boston, Massachusetts
- Aakha BiologicsBoard Observer2023 — 2026Dallas, TX
- Ypsilon TherapeuticsBoard Observer2022 — 2026Houston, TX
- Ypsilon TherapeuticsHead of Corporate Development & Operations2022 — 2026Houston, TX
- Alloy Therapeutics, Inc.82VS, Venture Studio of Alloy Therapeutics2021 — 2026Boston, MA
- Georgia Institute of TechnologyGraduate Research Assistant2017 — 2021Atlanta, Georgia
- University of Missouri-ColumbiaUndergraduate Research Assistant2014 — 2017Columbia, Missouri
- NASA Ames Research CenterSpace Life Science Traning Program Intern2016Mountain View, California
- University of Missouri Success CenterMath Tutor2014 — 2016Columbia, MO
- National Science Foundation (NSF)NSF Undergraduate Research Fellow2013 — 2014University of Missouri
Education
- Georgia Institute of TechnologyDoctor of Philosophy, Biomedical Engineering2017 — 2021
- University of Missouri-ColumbiaBachelors of Science, Bioengineering2013 — 2017
Skills & more
Research10Time Management6Biomedical Engineering2Molecular Biology2BiotechnologyPresentation Skills1Community Outreach1BioengineeringCRISPR/Cas9Gene EditingDrug DeliveryNanomedicine
+12 more
Systems BiologyDNA SequencingAnimal WorkAnimal HandlingCell BiologyLife SciencesMicrosoft OfficeMatlabTeamworkCritical ThinkingOrganization SkillsCommunication- VC University — VC University
From Melissa's professional profile.
Same school
Also attended Georgia Institute of Technology169
Brando De CourtenData Engineer at P101 VenturesTom DyalCo-Founder at Redpoint VenturesWill McGinnisEntrepreneur and data science executive working at the intersection of AI/ML, technology, and business strategyRaymond WangInvestor at GGV CapitalJaya GuptaInvestor at Foundation CapitalJames WangGeneral Partner at Creative Ventures
+ 163 more
Also attended University of Missouri-Columbia49
Dea SurjadiSpecial Advisor at Golden Gate VenturesTed CarstensenPlatform Team Manager at HeavybitAnna OglodzinskaExecutive Assistant at Sapphire VenturesChris KraeuterHead of Communications at ParadigmJeff SturmanExecutive Venture Partner at Caduceus Capital PartnersRebecca LynnManaging Director at Canvas Ventures
%20(1).png)
+ 43 more
Shared employers
Also worked at Aakha Biologics2
Also worked at Ypsilon Therapeutics2
Also worked at Alloy Therapeutics, Inc.19
Jesse RobbinsFounder and Investor in AI Developer ToolsChaya PatelPrincipal at Mission BiocapitalAlasdair ThongFounding Partner at Selvedge VentureEsra BerkolChief of Staff at Selvedge VentureMike SchmidtGeneral Partner, President and Head of 82VS Boston at 82VSVic StoneGeneral Partner, President and Head of 82VS Dallas at 82VS
+ 13 more
Also worked at Georgia Institute of Technology29
Brando De CourtenData Engineer at P101 VenturesBlake PattonFounder & Managing Partner at Tech Square VenturesMichael MeallingGeneral Partner at Starbridge Venture Capital LlcLily JooVenture Partner at VentureFriendsAndrew ShortFellow, Soil Biology at Prime Movers LabKathy PhamInvestor at Blue Tulip Ventures
+ 23 more
Colleagues at 82VS
Andrei Ramirez-Valdez
Venture Associate at 82VS
Andrew Peterson
Founder / EIR at 82VS
Arthur Suckow
Investor at 82VS
Caitlin Tolman
Chief Operating Officer at 82VS
Carlos Loya
Venture Partner & Founder at 82VS
Colby Jordan
Vice President, Capital Formation at 82VS
Dongxing Zha
Founder / EIR at 82VS
Errik Anderson
General Partner at 82VS